D-807-2013 Class III Terminated
FDA drug recall D-807-2013 was initiated by Bayer HealthCare Pharmaceuticals Inc. on Jun 13, 2013 and is designated Class III. Reason for recall: Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point. The recall status is terminated (terminated Feb 10, 2014). Affected quantity: 194.62 kg.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 24, 2013
- Initiation Date
- Jun 13, 2013
- Termination Date
- Feb 10, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 194.62 kg
Product description
Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin
Reason for recall
Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.
Distribution pattern
NY, CA
Code information
Lot 87100040
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-807-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026